Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion type Assertion NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_head.
- NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion description "[Expressions of 5- and 12-LOX in prostate cancer (PC) patients, prostatic intraepithelial neoplasia (PIN), benign prostatic hyperplasia (BPH), and normal prostate (NP) tissues were examined, as well as effects of their inhibitors on cell proliferation in 2 PC cell lines (PC3, DU-145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_provenance.
- NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion evidence source_evidence_literature NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_provenance.
- NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion SIO_000772 15010818 NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_provenance.
- NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion wasDerivedFrom befree-2016 NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_provenance.
- NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_assertion wasGeneratedBy ECO_0000203 NP434956.RAuWs9lthREgII_UMkaqqg2lBZBK9h3gQIL-VdRkIuFjw130_provenance.